Moderna Or Pfizer Booster Works Well For Those Vaccinated With J&J: Study.

Moderna Or Pfizer Booster Works Well For Those Vaccinated With J&J: Study

Researchers have analyzed antibody levels 15 days after the booster shot. (File)

Washington:

People who received Johnson & Johnson's Covid-19 vaccine may benefit from a booster dose of Pfizer or Moderna, preliminary results of a US study published Wednesday showed.

The study, funded by the National Institutes of Health (NIH), was eagerly awaited in the United States because it looked at the possibility of "mixing" vaccines -- using a different vaccine than the initial doses for the booster shot -- which is not currently allowed in the country.

The study was conducted on 458 adults who had been vaccinated with one of three US-approved brands (Pfizer, Moderna or J&J) for at least 12 weeks.

These three groups were each divided into three new groups to receive one of the available vaccines as a booster. The nine groups consisted of about 50 people each.

Researchers then analyzed antibody levels 15 days after the booster shot.

For people originally inoculated with J&J, antibody levels were four times higher after a J&J booster, 35 times higher after a Pfizer booster and 76 times higher after a Moderna booster.

And antibody levels for those who had originally received Moderna shots were higher "irrespective of the booster vaccine administered," when compared with those who had initially received Pfizer or J&J, the study said.

Additionally, "no safety concerns were identified" after booster doses were administered, it found.

The study, which has not yet been peer-reviewed, has several limitations, however.

The number of participants was small, and the immune response could evolve over time, beyond the 15 days observed during the study.

"Important not to get too carried away with the findings," tweeted Peter Hotez, a professor at Baylor College of Medicine.

Results from trials on a second J&J booster shot conducted by the company itself were "impressive," he said.

The NIH study should fuel discussions by a US Food and Drug Administration (FDA) expert committee, which is scheduled to consider applications for a booster dose from Moderna and J&J on Thursday and Friday, respectively.

A booster from Pfizer has already been approved in the United States for certain populations, such as people aged 65 or older, adults with high-risk medical conditions and those in jobs where they are frequently exposed to the coronavirus.

(Except for the headline, this story has not been edited by NDTV staff and is published from a syndicated feed.)

NDTV News

NDTV.com provides latest news from India and the world. Get today’s news headlines from Business, Technology, Bollywood, Cricket, videos, photos, live news coverage and exclusive breaking news from India.

https://www.ndtv.com/

Related news
Former Minneapolis officer Mohamed Noor sentenced to prison for manslaughter.

Former Minneapolis officer Mohamed Noor sentenced to prison for manslaughter.

A Minnesota judge sentenced former Minneapolis police officer Mohamed Noor to nearly five years in prison Thursday for the 2017 fatal shooting of Justine Ruszczyk Damond. Noor was initially convicted of third-degree murder and manslaughter, but th...

Moscow announces one-week COVID-19 lockdown

Moscow announces one-week COVID-19 lockdown

CBS News reporter Mary Ilyushina reports from Moscow on the city's one-week lockdown as COVID-19 cases surge in Russia. CBSN is CBS News’ 24/7 digital streaming news service featuring live, anchored coverage available for free across all platforms...

How Covid Vaccine Hesitancy Impacts Herd Immunity

How Covid Vaccine Hesitancy Impacts Herd Immunity

More than half of adults in the U.S. have had at least one dose of a Covid-19 vaccine, but health experts warn that vaccine hesitancy is slowing down the chances of reaching herd immunity. Epidemiologist at the University of Pennsylvania School of...

Morning News NOW Full Broadcast - October 21

Morning News NOW Full Broadcast - October 21

The FDA approves a booster shot for the Moderna and Johnson & Johnson Covid vaccines, human remains are found in the area authorities were searching for Brian Laundrie, a person of interest in the death of his girlfriend, Gabby Petito, and Preside...

Liberal backlash against Sinema grows

Liberal backlash against Sinema grows

Five of Sen. Kyrsten Sinema's military veteran advisers resign and say she is one of the "principal obstacles to progress" as she continues to battle Democrats on Biden's agenda. #CNN #News

Live: White House Holds Press Briefing - NBC News

Live: White House Holds Press Briefing - NBC News

Watch as White House Principal Deputy Press Secretary Karine Jean-Pierre holds a press briefing. » Subscribe to NBC News: » Watch more NBC video: NBC News Digital is a collection of innovative and powerful news brands that deliver compelling, dive...